Patents by Inventor Eva Skiöldebrand

Eva Skiöldebrand has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210386744
    Abstract: There is provided a new treatment for osteoarthritis in horses, which involves the administration of a phosphodiesterase type 5 (PDE5) inhibitor, for example sildenafil in a low dose, to the patient. Preferably, sildenafil is combined with the local anaesthetic mepivacaine and with glucose.
    Type: Application
    Filed: October 25, 2019
    Publication date: December 16, 2021
    Inventors: Eva SKIÖLDEBRAND, Elisabeth HANSSON RÖNNBÄCK
  • Publication number: 20190137514
    Abstract: There is provided a peptide comprising the amino acid sequence N-terminal-SGPTH and an antibody against this peptide. The peptide can be used for diagnosis in humans and animals, in particular horses. In particular the antibody can be used for diagnosis of a systemic low-grade chronic inflammatory disease such as osteoarthritis or atherosclerosis, or a neurodegenerative disease or neuroinflammatory disease.
    Type: Application
    Filed: June 15, 2017
    Publication date: May 9, 2019
    Inventors: Eva Skiöldebrand, Anders Lindahl, Stina Ekman